Amyris traded at $0.01 this Tuesday April 9th, increasing $0.003 or 150.00 percent since the previous trading session. Looking back, over the last four weeks, Amyris gained 0 percent. Over the last 12 months, its price fell by 99.61 percent. Looking ahead, we forecast Amyris to be priced at 0.005 by the end of this quarter and at 0.004 in one year, according to Trading Economics global macro models projections and analysts expectations.
Amyris, Inc. is a synthetic biotechnology company. The Company applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The Company's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The Company is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance.